thioguanine - CISMeF

Preferred Label : thioguanine;

MeSH definition : An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.;

MeSH synonym : 6-thioguanine; 6 thioguanine; Tioguanine; 2-Amino-6-Purinethiol; 2 Amino 6 Purinethiol;

CISMeF synonym : glaxo wellcome, thioguanin; tabloid, thioguanine; hemihydrate, thioguanine; thioguanin glaxo wellcome; wellcome, thioguanin glaxo; GlaxoSmithKline brand of thioguanine; GlaxoSmithKline brand of tioguanine; tioguanine GlaxoSmithKline brand; wellcome brand of thioguanine; glaxo wellcome brand of tioguanine; glaxo wellcome brand of thioguanine;

MeSH hyponym : thioguanine hemihydrate; lanvis; thioguanine monosodium salt; tabloid; tioguanina wellcome; thioguanine anhydrous; Thioguanine Tabloid; Thioguanin-GSK; Thioguanin GSK; ThioguaninGSK; Anhydrous, Thioguanine;

MeSH CAS label : 6H-Purine-6-thione, 2-amino-1,7-dihydro-;

MeSH Related Number : thioguanine monosodium salt; thioguanine hemihydrate; 154-42-7 (Thioguanine); 5580-03-0 (hemihydrate); 76078-67-6 (mono-Na salt); thioguanine anhydrous; WIX31ZPX66;

Registry Number MeSH : 154-42-7;

Related CAS MeSH : 76078-67-6 (Thioguanine monosodium salt); 5580-03-0 (Thioguanine hemihydrate); WIX31ZPX66 (Thioguanine anhydrous);

Wikipedia link : https://en.wikipedia.org/wiki/Tioguanine;

Codes EINECS : 205-827-2;

Is substance : O;

UNII : FTK8U1GZNX;

InChIKey : VOXBZHOHGGBLCQ-UHFFFAOYSA-N;

Details

Origin ID

D013866;

UMLS CUI

C0039902;

ATC code(s)
- tioguanine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Thioguanine poisoning (disorder) [SNOMED CT concept]
- thioguanine [Substance BNPC]
Pharmacological action(s)
- antimetabolites, antineoplastic [MeSH Descriptor]
Record concept(s)
- lanvis [MeSH concept]
- tabloid [MeSH concept]
- thioguanine [MeSH concept]
- thioguanine anhydrous [MeSH concept]
- thioguanine hemihydrate [MeSH concept]
- thioguanine monosodium salt [MeSH concept]
- tioguanina wellcome [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-deaza-6-thioguanine [MeSH Supplementary Concept]
- 2-amino-9-(2-(phosphonomethoxy)ethyl)-6-sulfanylpurine [MeSH Supplementary Concept]
- 6-(decyldithio)-1H-purin-2-amine [MeSH Supplementary Concept]
- 6-(phenyldithio)-1H-purin-2-amine [MeSH Supplementary Concept]
- 6-methylthioguanine [MeSH Supplementary Concept]
- 6-thio-3-deazaguanine [MeSH Supplementary Concept]
- 6-thioguainine disulfide [MeSH Supplementary Concept]
- 8-hydroxythioguanine [MeSH Supplementary Concept]
- 9-(n-butyl)-6-thioguanine [MeSH Supplementary Concept]
- ACT protocol [MeSH Supplementary Concept]
- ATA protocol [MeSH Supplementary Concept]
- BACT protocol [MeSH Supplementary Concept]
- BF-9 protocol [MeSH Supplementary Concept]
- BFM 78 protocol [MeSH Supplementary Concept]
- Berlin-Frankfurt-Muenster protocol II [MeSH Supplementary Concept]
- CART protocol [MeSH Supplementary Concept]
- COATA protocol [MeSH Supplementary Concept]
- CT protocol [MeSH Supplementary Concept]
- D(A)AT protocol [MeSH Supplementary Concept]
- DAT protocol 1 [MeSH Supplementary Concept]
- DAT-COAP regimen [MeSH Supplementary Concept]
- DATOP protocol [MeSH Supplementary Concept]
- DATV regimen [MeSH Supplementary Concept]
- DCTER protocol [MeSH Supplementary Concept]
- DCTP regimen [MeSH Supplementary Concept]
- ETI protocol [MeSH Supplementary Concept]
- HAT regimen [MeSH Supplementary Concept]
- HATP protocol [MeSH Supplementary Concept]
- HOAGP protocol [MeSH Supplementary Concept]
- HR-2 protocol [MeSH Supplementary Concept]
- L-6 protocol [MeSH Supplementary Concept]
- LSA(2)L(2) protocol [MeSH Supplementary Concept]
- MI-MIV maintenance protocol [MeSH Supplementary Concept]
- N2,3-etheno-6-thioguanine [MeSH Supplementary Concept]
- NSC35866 [MeSH Supplementary Concept]
- PACET protocol [MeSH Supplementary Concept]
- PATCO protocol [MeSH Supplementary Concept]
- POCAL protocol [MeSH Supplementary Concept]
- POG-8498 protocol [MeSH Supplementary Concept]
- RATE protocol [MeSH Supplementary Concept]
- TACC protocol [MeSH Supplementary Concept]
- TAPA protocol [MeSH Supplementary Concept]
- TGAP protocol [MeSH Supplementary Concept]
- TOAP protocol [MeSH Supplementary Concept]
- TPDC-FuHu protocol [MeSH Supplementary Concept]
- TPDCV protocol [MeSH Supplementary Concept]
- TRAMPCO protocol [MeSH Supplementary Concept]
- TRAMPCOL protocol [MeSH Supplementary Concept]
- VATA protocol [MeSH Supplementary Concept]
- guanine-6-thioguanine [MeSH Supplementary Concept]
- new york protocol [MeSH Supplementary Concept]
- palladium thioguanine [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing tioguanine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 6-Thioguanine [LOINC component]
- Product containing tioguanine (medicinal product) [SNOMED CT concept]
- Thioguanine [ICD-11 Extension code]
- Thioguanine [NCIt concept]
- Thioguanine [LOINC component]
- Tioguanine [ICD-11 Extension code]
- Tioguanine (substance) [SNOMED CT concept]
- thioguanine [Substance BNPC]
- thioguanine [SNOMED Notion]
- tioguanine [ATC Code]
Validated automatic mappings to BTNT
- Thioguanine Anhydrous [NCIt concept]
- tioguanine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients